| Product Code: ETC7744993 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Parkinsons Disease Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Parkinsons Disease Market - Industry Life Cycle |
3.4 Japan Parkinsons Disease Market - Porter's Five Forces |
3.5 Japan Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Japan Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Japan Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Japan Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Japan Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Japan Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Parkinson's disease in Japan |
4.2.2 Growing awareness about early diagnosis and treatment options |
4.2.3 Advancements in research and development of new therapies for Parkinson's disease |
4.3 Market Restraints |
4.3.1 High cost of treatment and medications for Parkinson's disease |
4.3.2 Lack of skilled healthcare professionals specializing in Parkinson's disease management |
4.3.3 Limited access to specialized care facilities for Parkinson's patients in Japan |
5 Japan Parkinsons Disease Market Trends |
6 Japan Parkinsons Disease Market, By Types |
6.1 Japan Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Japan Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Japan Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Japan Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Japan Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Japan Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Japan Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Japan Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Japan Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Japan Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Japan Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Japan Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Japan Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Japan Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Japan Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Japan Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Japan Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Japan Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Japan Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Japan Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Japan Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Japan Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Japan Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Japan Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Japan Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Japan Parkinsons Disease Market Export to Major Countries |
7.2 Japan Parkinsons Disease Market Imports from Major Countries |
8 Japan Parkinsons Disease Market Key Performance Indicators |
8.1 Average age of diagnosis of Parkinson's disease in Japan |
8.2 Number of clinical trials for Parkinson's disease treatments conducted in Japan |
8.3 Percentage of Parkinson's disease patients receiving regular follow-up care and support |
8.4 Adoption rate of new Parkinson's disease treatment guidelines in clinical practice |
9 Japan Parkinsons Disease Market - Opportunity Assessment |
9.1 Japan Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Japan Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Japan Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Japan Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Japan Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Japan Parkinsons Disease Market - Competitive Landscape |
10.1 Japan Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Japan Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here